• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于预测细胞减灭术和 HIPEC 治疗腹膜癌病术后感染性并发症的炎症生物标志物。

Inflammatory biomarkers to predict postoperative infectious complications after cytoreductive surgery and HIPEC for peritoneal carcinomatosis.

机构信息

Department of Digestive and Endocrine Surgery, University Hospital of Reims, Reims, France; University of Champagne Ardenne, France.

Department of Digestive and Endocrine Surgery, University Hospital of Reims, Reims, France; University of Champagne Ardenne, France.

出版信息

Eur J Surg Oncol. 2022 Feb;48(2):455-461. doi: 10.1016/j.ejso.2021.09.015. Epub 2021 Sep 21.

DOI:10.1016/j.ejso.2021.09.015
PMID:34565632
Abstract

BACKGROUND

Early detection of postoperative infectious complications (IC) is crucial after Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). The aim of this study was to evaluate the predictive role of early postoperative inflammatory biomarkers level for the detection of postoperative IC.

METHODS

a retrospective study was performed including 199 patients treated with complete CRS/HIPEC for PC from various primary origins from September 2012 to January 2021. Patients were monitored by a routine measurement of inflammatory biomarkers (CRP, leukocytes, neutrophils, lymphocytes, neutrophile-to-lymphocyte ratio and platelets-to-lymphocyte ratio). Inflammatory biomarkers were compared between patients with vs without IC.

RESULTS

IC occurred for 68 patients (34.2%). CRP values were significantly higher in patients with IC on POD 3, 5 and 7 (CRP = 166 mg/L [128-244], 155 mg/L [102-222] and 207 mg/L [135-259], respectively). The CRP on POD7, with a cut-off value of 100 mg/L, was an excellent predictor of postoperative IC (AUC = 90.1%). The CRP on POD 5, with a cut-off value of 90 mg/L, was a good predictor of postoperative IC (AUC = 83.2%). NLR values were significantly higher in patients with IC on POD 3, 5 and 7. NLR on POD 5 and 7 higher than 9.7 and 6.3, respectively, were fair predictors (AUC = 70.8 and 79.6, respectively).

CONCLUSION

CRP levels between POD3 and 7 are the best predictors of postoperative IC after CRS/HIPEC. The presence of postoperative IC should be suspected in patients with CRP higher than 140 mg/L, 90 mg/L or 100 mg/L on PODs 3, 5 or 7.

摘要

背景

细胞减灭术联合腹腔热灌注化疗(CRS/HIPEC)后,早期发现术后感染性并发症(IC)至关重要。本研究旨在评估术后早期炎症生物标志物水平对术后 IC 检测的预测作用。

方法

回顾性研究纳入了 2012 年 9 月至 2021 年 1 月期间因各种原发部位 PC 接受完全 CRS/HIPEC 治疗的 199 例患者。通过常规测量炎症生物标志物(CRP、白细胞、中性粒细胞、淋巴细胞、中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值)对患者进行监测。比较了有和无 IC 患者之间的炎症生物标志物。

结果

68 例患者(34.2%)发生 IC。IC 患者术后第 3、5、7 天 CRP 值明显升高(CRP=166mg/L[128-244]、155mg/L[102-222]和 207mg/L[135-259])。术后第 7 天 CRP 以 100mg/L 为界值,对术后 IC 的预测效果最佳(AUC=90.1%)。CRP 术后第 5 天,以 90mg/L 为界值,对术后 IC 的预测效果较好(AUC=83.2%)。NLR 值在术后第 3、5、7 天 IC 患者中明显升高。NLR 术后第 5、7 天高于 9.7 和 6.3,预测效果为中等(AUC 分别为 70.8 和 79.6)。

结论

CRS/HIPEC 术后第 3 至 7 天 CRP 水平是术后 IC 的最佳预测指标。术后第 3、5、7 天 CRP 高于 140mg/L、90mg/L 或 100mg/L 时,应怀疑存在术后 IC。

相似文献

1
Inflammatory biomarkers to predict postoperative infectious complications after cytoreductive surgery and HIPEC for peritoneal carcinomatosis.用于预测细胞减灭术和 HIPEC 治疗腹膜癌病术后感染性并发症的炎症生物标志物。
Eur J Surg Oncol. 2022 Feb;48(2):455-461. doi: 10.1016/j.ejso.2021.09.015. Epub 2021 Sep 21.
2
The Safety of Iterative Cytoreductive Surgery and HIPEC for Peritoneal Carcinomatosis: A High Volume Center Prospectively Maintained Database Analysis.多次细胞减灭术和 HIPEC 治疗腹膜癌转移的安全性:大容量中心前瞻性维护数据库分析。
Ann Surg Oncol. 2020 May;27(5):1448-1455. doi: 10.1245/s10434-019-08141-w. Epub 2019 Dec 23.
3
Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.细胞减灭术和腹腔内热灌注化疗后高级别阑尾或结直肠腹膜癌转移进展的预测因素
Ann Surg Oncol. 2015 May;22(5):1716-21. doi: 10.1245/s10434-014-3985-y. Epub 2014 Aug 22.
4
Postoperative C-reactive protein kinetics predict postoperative complications in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.对于接受减瘤手术及腹腔热灌注化疗治疗腹膜癌病的患者,术后C反应蛋白动力学可预测术后并发症。
World J Surg Oncol. 2020 Nov 26;18(1):311. doi: 10.1186/s12957-020-02081-6.
5
Postoperative time course and utility of inflammatory markers in patients with ovarian peritoneal carcinomatosis treated with neoadjuvant chemotherapy, cytoreductive surgery, and HIPEC.新辅助化疗、肿瘤细胞减灭术及腹腔热灌注化疗治疗卵巢腹膜癌患者的术后炎症标志物变化过程及应用价值
Ann Surg Oncol. 2015 Apr;22(4):1332-40. doi: 10.1245/s10434-014-4096-5. Epub 2014 Sep 19.
6
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer: The prognostic impact of baseline neutrophil-lymphocyte, platelet-lymphocyte and lymphocyte-monocyte ratios.结直肠癌腹膜转移患者行细胞减灭术联合腹腔热灌注化疗:基线中性粒细胞-淋巴细胞、血小板-淋巴细胞和淋巴细胞-单核细胞比值的预后影响。
Surg Oncol. 2020 Dec;35:321-327. doi: 10.1016/j.suronc.2020.09.002. Epub 2020 Sep 14.
7
Predictive value of C-reactive protein levels for the early and later detection of postoperative complications after cytoreductive surgery and HIPEC.C反应蛋白水平对减瘤手术及腹腔热灌注化疗术后并发症早期及后期检测的预测价值
Front Oncol. 2022 Oct 25;12:943522. doi: 10.3389/fonc.2022.943522. eCollection 2022.
8
Peritoneal cancer index (PCI) based patient selecting strategy for complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis: A single-center retrospective analysis of 125 patients.基于腹膜癌指数(PCI)的患者选择策略用于胃癌伴腹膜转移行完全细胞减灭术加腹腔热灌注化疗:一项单中心回顾性分析 125 例患者。
Eur J Surg Oncol. 2021 Jun;47(6):1411-1419. doi: 10.1016/j.ejso.2020.11.139. Epub 2020 Dec 1.
9
Outcomes in Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).阑尾杯状细胞腺癌行细胞减灭术和腹腔热灌注化疗(CRS/HIPEC)治疗后的腹膜转移癌结局。
Ann Surg Oncol. 2020 Jan;27(1):179-187. doi: 10.1245/s10434-019-07932-5. Epub 2019 Oct 23.
10
Toxicity profile of chemotherapy agents used in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies.细胞减灭术和腹腔内热灌注化疗治疗腹膜表面恶性肿瘤中使用的化疗药物的毒性特征。
Eur J Surg Oncol. 2020 Apr;46(4 Pt A):577-581. doi: 10.1016/j.ejso.2019.10.032. Epub 2019 Oct 26.

引用本文的文献

1
C-reactive protein and digestive pathologies: A narrative review for daily clinical use.C反应蛋白与消化系统疾病:日常临床应用的叙述性综述
J Res Med Sci. 2025 Feb 28;30:10. doi: 10.4103/jrms.jrms_537_23. eCollection 2025.
2
Return to Intended Oncological Therapy: State of the Art and Perspectives.返回计划的肿瘤学治疗:现状与展望。
Curr Oncol Rep. 2024 Nov;26(11):1420-1430. doi: 10.1007/s11912-024-01594-7. Epub 2024 Sep 25.
3
Predictive Value of C-Reactive Protein for Infectious Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Single-Center Prospective Study.
C 反应蛋白对细胞减灭术和腹腔热灌注化疗后感染并发症的预测价值:一项单中心前瞻性研究。
Ann Surg Oncol. 2024 Dec;31(13):8538-8548. doi: 10.1245/s10434-024-15986-3. Epub 2024 Aug 12.